Skip to main content
. Author manuscript; available in PMC: 2015 Feb 15.
Published in final edited form as: Clin Cancer Res. 2013 Dec 3;20(4):827–836. doi: 10.1158/1078-0432.CCR-13-2053

Table 1.

Cox Proportional Hazards Model for Progression Free Survival (Patients who received irradiation as part of the primary treatment were censored at time of irradiation)

Variables Univariate Analyses Multivariate Analyses

HR1 95% CI1 p1 HR2 95% CI2 p2 HR3 95% CI3 p3
Age at Diagnosis
Relative risk increase per 1 year 1.2 (1.05, 1.4) 0.017 1.0 (0.84, 1.3) 0.78 Not included in the model
>=3 year vs. <3 year 3.5 (1.3, 9.1) 1.2 (0.36, 3.8)

Stage4
M0 1.0 -- 0.006 1.0 -- 0.004 1.0 -- 0.002
M+ 4.7 (1.4, 15) 16 (2.0, 128) 7.9 (1.8, 34)

Histology4
Classic 1.0 -- 0.21 1.0 -- 0.27
Desmoplastic/nodular 0.42 (0.09, 2.0) 3.8 (0.29, 49) Not included in the model
Anaplastic/Large Cell 2.0 (0.54, 7.6) 0.35 (0.06, 1.9)

Molecular Subgroup4
SHH/WNT 1.0 -- 0.048 1.0 -- 0.75
Group 3 6.2 (1.5, 26) 2.7 (0.17, 44) Not included in the model
Group 4 3.2 (0.58, 18) 2.1 (0.12, 37)

PID1
High 1.0 -- 1.0 -- 1.0 --
Low 6.8 (2.2, 21) <0.001 21 (1.9, 221) 0.005 12.1 (2.8, 52) <0.001

Abbreviations: HR, hazard ratio; CI, confidence interval.

1

HR and CI from univariate Cox models.

2

HR, CI and p-values from the Cox model that included age, stage, histology, molecular subgroup and PID1 expression.

3

HR, CI and p-values from the Cox model that included stage and PID1 expression.

4

Missing data for these variables were included in the models as a “missing” category.